n.肾胚细胞瘤；肾胚胎瘤；肾胚胎性癌肉瘤；成肾细胞瘤

Nephroblastoma, also known as Wilms' tumor, is a rare form of kidney cancer that predominantly affects children.
肾母细胞瘤，也称为威尔姆斯肿瘤，是一种罕见的肾脏癌症，主要影响儿童。
Early detection and treatment of nephroblastoma are crucial for a favorable prognosis in pediatric patients.
早期发现和治疗肾母细胞瘤对于儿童患者的预后至关重要。
The primary treatment for nephroblastoma often involves surgery, chemotherapy, and radiation therapy.
肾母细胞瘤的主要治疗方法通常包括手术、化疗和放疗。
Imaging studies such as ultrasound and CT scans play a pivotal role in diagnosing nephroblastoma.
超声波和CT扫描等影像学检查在肾母细胞瘤的诊断中起着关键作用。
Nephroblastoma survivors often require long-term monitoring for potential recurrence or complications related to the treatment.
肾母细胞瘤幸存者往往需要长期监测，以防复发或治疗相关的并发症。
Research continues to explore targeted therapies for nephroblastoma, aiming to improve patient outcomes.
研究继续探索针对肾母细胞瘤的靶向疗法，以提高患者疗效。
Genetic mutations are associated with an increased risk of developing nephroblastoma, particularly in certain familial cases.
遗传突变与肾母细胞瘤的风险增加有关，特别是在某些家族性病例中。
Children with nephroblastoma often experience symptoms like abdominal pain, blood in the urine, and swelling in the abdomen.
患有肾母细胞瘤的儿童常常会出现腹痛、尿液带血以及腹部肿胀等症状。
Supportive care, including pain management and emotional counseling, is just as important as medical treatment for nephroblastoma patients.
对肾母细胞瘤患者的护理支持，包括疼痛管理与心理辅导，与医疗治疗同等重要。
Advances in nephroblastoma treatment have led to improved survival rates and better quality of life for affected children.
肾母细胞瘤治疗的进步已经提高了受影响儿童的生存率和生活质量。